These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21809264)

  • 21. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders.
    Nijhawan A; Baselga E; Gonzalez-Ensenat MA; Vicente A; Southern JF; Camitta BM; Esterly NB; Drolet BA
    Arch Dermatol; 2001 Jun; 137(6):760-3. PubMed ID: 11405767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
    Dewald GW; Diez-Martin JL; Steffen SL; Jenkins RB; Stupca PJ; Burgert EO
    Am J Med Genet Suppl; 1990; 7():247-50. PubMed ID: 2149957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocythemia in the myeloproliferative disorder of Down's syndrome.
    Miller JM; Sherrill JG; Hathaway WE
    Pediatrics; 1967 Nov; 40(5):847-50. PubMed ID: 4229443
    [No Abstract]   [Full Text] [Related]  

  • 25. The hematologic evaluation of the urologic patient.
    Cassileth PA
    Urol Clin North Am; 1976 Jun; 3(2):255-66. PubMed ID: 960310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologic abnormalities in children with Down syndrome.
    Roizen NJ; Amarose AP
    Am J Med Genet; 1993 Jun; 46(5):510-2. PubMed ID: 8322810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and clinical relevance of abnormal complete blood counts in long-term survivors of childhood cancer.
    Long ZB; Oeffinger KC; Brooks SL; Fischbach L; Harris TR; Eshelman DA; Tomlinson GE; Buchanan GR
    Cancer; 2006 Apr; 106(7):1634-40. PubMed ID: 16502409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.
    Dixon N; Kishnani PS; Zimmerman S
    Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):149-57. PubMed ID: 17048354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematological characteristics in neonates with twin anemia-polycythemia sequence (TAPS).
    Lopriore E; Slaghekke F; Oepkes D; Middeldorp JM; Vandenbussche FP; Walther FJ
    Prenat Diagn; 2010 Mar; 30(3):251-5. PubMed ID: 20087909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
    Homans AC; Verissimo AM; Vlacha V
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia in neonates with trisomy 21.
    Hord JD; Gay JC; Whitlock JA
    Arch Pediatr Adolesc Med; 1995 Jul; 149(7):824-5. PubMed ID: 7795778
    [No Abstract]   [Full Text] [Related]  

  • 34. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.
    Shimada A; Hayashi Y; Ogasawara M; Park MJ; Katoh M; Minakami H; Kitoh T; Kojima S; Kawa K; Kimura H
    Leuk Res; 2007 Sep; 31(9):1199-203. PubMed ID: 17055049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system.
    Christensen RD; Henry E; Wiedmeier SE; Stoddard RA; Lambert DK
    J Perinatol; 2006 Nov; 26(11):682-7. PubMed ID: 17036034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Hematological Disorders in Mosaic Down Syndrome: Parent Report of Experiences.
    Santoro SL; Martin LJ; Hopkin RJ
    Clin Pediatr (Phila); 2016 May; 55(5):421-7. PubMed ID: 26084538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features of transient myeloproliferative syndrome and congenital leukaemia.
    Sajid N; Ahmed N; Mahmood S
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):576-80. PubMed ID: 20810047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system.
    Christensen RD; Henry E; Wiedmeier SE; Stoddard RA; Sola-Visner MC; Lambert DK; Kiehn TI; Ainsworth S
    J Perinatol; 2006 Jun; 26(6):348-53. PubMed ID: 16642027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.